These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7605357)

  • 1. Extraction of lipoprotein(a), apo B, and apo E from fresh human arterial wall and atherosclerotic plaques.
    Reblin T; Meyer N; Labeur C; Henne-Bruns D; Beisiegel U
    Atherosclerosis; 1995 Mar; 113(2):179-88. PubMed ID: 7605357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients.
    Rath M; Niendorf A; Reblin T; Dietel M; Krebber HJ; Beisiegel U
    Arteriosclerosis; 1989; 9(5):579-92. PubMed ID: 2528948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of apo[a] and apoB in human atherosclerotic lesions.
    Pepin JM; O'Neil JA; Hoff HF
    J Lipid Res; 1991 Feb; 32(2):317-27. PubMed ID: 1829751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemically detectable lipid-free apo(a) in plasma and in human atherosclerotic lesions.
    Hoff HF; O'Neil J; Smejkal GB; Yashiro A
    Chem Phys Lipids; 1994 Jan; 67-68():271-80. PubMed ID: 8187224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modified lipoproteins in atherosclerotic lesions of human aorta].
    Wang X; Chen Q; Zhu Q
    Zhonghua Bing Li Xue Za Zhi; 1998 Feb; 27(1):6-9. PubMed ID: 11244945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial characterization of lipoproteins containing apo[a] in human atherosclerotic lesions.
    Hoff HF; O'Neil J; Yashiro A
    J Lipid Res; 1993 May; 34(5):789-98. PubMed ID: 8509717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The apolipoprotein(a) component of lipoprotein(a) mediates binding to laminin: contribution to selective retention of lipoprotein(a) in atherosclerotic lesions.
    D'Angelo A; Geroldi D; Hancock MA; Valtulina V; Cornaglia AI; Spencer CA; Emanuele E; Calligaro A; Koschinsky ML; Speziale P; Visai L
    Biochim Biophys Acta; 2005 Feb; 1687(1-3):1-10. PubMed ID: 15708348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype.
    Guo HC; Chapman MJ; Bruckert E; Farriaux JP; De Gennes JL
    Atherosclerosis; 1991 Jan; 86(1):69-83. PubMed ID: 1829609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression of apolipoprotein(a) within the wall of human aorta and carotid arteries.
    Fu L; Jamieson DG; Usher DC; Lavi E
    Atherosclerosis; 2001 Oct; 158(2):303-11. PubMed ID: 11583708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100.
    Koschinsky ML; Côté GP; Gabel B; van der Hoek YY
    J Biol Chem; 1993 Sep; 268(26):19819-25. PubMed ID: 8366120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic predisposition for the multiple metabolic syndrome. Part 4. Apolipoprotein E and lipoprotein (a)].
    Sobra J; Ceska R
    Cas Lek Cesk; 1999 Mar; 138(7):203-8. PubMed ID: 10510535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a).
    Seman LJ; Breckenridge WC
    Biochem Cell Biol; 1986 Oct; 64(10):999-1009. PubMed ID: 2948527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein(a) in the arterial wall.
    Beisiegel U; Niendorf A; Wolf K; Reblin T; Rath M
    Eur Heart J; 1990 Aug; 11 Suppl E():174-83. PubMed ID: 2146123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. II. Preferential immobilization of lipoprotein (a) (Lp(a)).
    Smith EB; Cochran S
    Atherosclerosis; 1990 Oct; 84(2-3):173-81. PubMed ID: 2149268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of two sub-species of Lp(a), one containing apo E and one free of apo E.
    Bard JM; Delattre-Lestavel S; Clavey V; Pont P; Derudas B; Parra HJ; Fruchart JC
    Biochim Biophys Acta; 1992 Jul; 1127(2):124-30. PubMed ID: 1322706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of weight loss and apolipoprotein E polymorphism on serum lipids, apolipoproteins A-I and B, and lipoprotein(a).
    Muls E; Kempen K; Vansant G; Cobbaert C; Saris W
    Int J Obes Relat Metab Disord; 1993 Dec; 17(12):711-6. PubMed ID: 8118476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apo B-containing lipoprotein particles in poorly controlled insulin-dependent diabetes.
    Igau B; Lestavel S; Clavey V; Slomianny C; Drouin P; Bresson R; Fruchart JC; Duriez P; Fiévet C
    Atherosclerosis; 1996 Feb; 120(1-2):209-19. PubMed ID: 8645362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).
    Sanan DA; Newland DL; Tao R; Marcovina S; Wang J; Mooser V; Hammer RE; Hobbs HH
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4544-9. PubMed ID: 9539774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoprotein B quantification in rhesus and cynomolgus monkey atherosclerotic lesions.
    Davis HR; Wissler RW
    Atherosclerosis; 1984 Mar; 50(3):241-52. PubMed ID: 6712774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of apolipoprotein E in normal and atherosclerotic human aorta.
    Babaev VR; Dergunov AD; Chenchik AA; Tararak EM; Yanushevskaya EV; Trakht IN; Sorg C; Smirnov VN
    Atherosclerosis; 1990 Dec; 85(2-3):239-47. PubMed ID: 2102087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.